News & Press Releases

Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.

Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.

Reimagining the future of scientific writing, Yseop Copilot leverages pre-trained cutting edge Generative AI models (LLMs) for the BioPharma industry.

Yseop has won at the 2023 Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials.

Yseop has been honored as a finalist in the 2023 Global Business Tech Awards for the Best Use of Artificial Intelligence in Clinical Trials.

Read the full article in Pharmaphorum. Across all industries, generative AI has become the latest buzz word. Talk of implementing automation and AI solutions to enhance human capacity continues to dominate conversations. In fact, venture capitalists have increased investment in generative AI by 425% since 2020 to $2.1 billion.

Yseop has been honored As finalist in the 2023 Citeline Awards for the Best Use of Artificial Intelligence in Clinical Trials.

The top natural language generation companies in 2023. NLG has become popular in recent years due to its content creation ability.